Completed
Dexpramipexole SAD/MAD Study
NCT01449578
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Research Site Overland Park, Kansas, United States